Healthcare Sales & Marketing Network News: Ranbaxy Pharmaceuticals

Searching News Database: Ranbaxy Pharmaceuticals

HSMN NewsFeed - 24 Apr 2015
Cipher Pharmaceuticals announces outcome of Markman hearing in patent infringement suit for Absorica(R)
Biopharmaceuticals Generics Litigation

HSMN NewsFeed - 8 May 2014
Acura Pharmaceuticals Announces Settlement of Patent Litigation With Ranbaxy Inc.
Biopharmaceuticals Generics Litigation

HSMN NewsFeed - 17 Aug 2012
Ranbaxy Launches Authorized Generic Of Pioglitazone In The U.S.
Biopharmaceuticals Generics Endocrinology

HSMN NewsFeed - 28 Apr 2010
Takeda Provides Update on Patent Litigation for ACTOS(R) (pioglitazone HCl) and ACTOplus met(R) (pioglitazone HCl and metformin HCl) in the U.S.
Biopharmaceuticals Litigation Endocrinology

HSMN NewsFeed - 15 Mar 2010
Ranbaxy Announces Settlement of Actos(R) (Pioglitazone Hydrochloride) Patent Litigation
Biopharmaceuticals Generics Litigation

HSMN NewsFeed - 6 Aug 2008
Cipher Pharmaceuticals announces U.S. distribution and supply agreement with Ranbaxy for CIP-ISOTRETINOIN
Biopharmaceuticals Distribution

HSMN NewsFeed - 28 Jul 2008
Ranbaxy Launches Omeprazole 40 mg Capsules
Biopharmaceuticals Generics

HSMN NewsFeed - 15 Apr 2008
Ranbaxy and AstraZeneca Reach Agreement in Esomeprazole Patent Litigation
Biopharmaceuticals Generics Litigation Distribution

HSMN NewsFeed - 7 Feb 2008
Ranbaxy Receives Tentative Approval to Manufacture and Market Esomeprazole Magnesium DR Capsules
Biopharmaceuticals FDA Generics

HSMN NewsFeed - 6 Feb 2008
Ranbaxy Gains Approval to Manufacture and Market Cefuroxime Axetil for Oral Suspension
Biopharmaceuticals FDA Generics

HSMN NewsFeed - 20 Nov 2007
Ranbaxy Launches Ran(R)-Tamsulosin Hydrochloride Capsules in Canada
Biopharmaceuticals Generics Regulatory

HSMN NewsFeed - 8 Nov 2007
Ranbaxy and Astellas/Boehringer Ingelheim Enter Into an Agreement to Resolve Tamsulosin U.S. Patent Litigation
Biopharmaceuticals Generics Litigation

HSMN NewsFeed - 29 Oct 2007
Ranbaxy Receives Tentative Approval For Valsartan Tablets
Biopharmaceuticals Generics FDA

HSMN NewsFeed - 6 Sep 2007
Ranbaxy Gains Approval to Manufacture and Market Carvedilol Tablets in the U.S. Market
Biopharmaceuticals Cardiology Generics FDA

HSMN NewsFeed - 30 Aug 2007
Ranbaxy Receives Tentative Approval to Manufacture and Market Galantamine Tablets on an Exclusive Basis
Biopharmaceuticals Generics FDA Neurology

HSMN NewsFeed - 20 Aug 2007
Ranbaxy Receives Approval to Manufacture and Market Hydrocodone Bitartrate and Acetaminophen Tablets USP
Biopharmaceuticals Generics FDA

HSMN NewsFeed - 10 Jul 2007
Ranbaxy Receives Final Approval To Manufacture and Market Amlodipine Besylate Tablets
Biopharmaceuticals Generics FDA

HSMN NewsFeed - 25 Jun 2007
Ranbaxy Launches Pravastatin Sodium 80 Mg Tablets
Biopharmaceuticals Generics

HSMN NewsFeed - 22 Jun 2007
Ranbaxy Receives Tentative Approval for Tamsulosin Capsules
Biopharmaceuticals Generics FDA

HSMN NewsFeed - 20 Jun 2007
Ranbaxy Receives Tentative Approval to Manufacture and Market Amlodipine Besylate Tablets
Biopharmaceuticals Generics FDA

HSMN NewsFeed - 29 May 2007
Ranbaxy Expands its Presence in the U.S. Dermatology Market Through the Acquisition of 13 Brands from Bristol Myers Squibb
Biopharmaceuticals Dermatology Acquisitions

HSMN NewsFeed - 17 May 2007
Ranbaxy Receives Tentative FDA Approval for Fexofenadine Hydrochloride Tablets
Biopharmaceuticals Generics FDA

HSMN NewsFeed - 26 Apr 2007
Ranbaxy Receives Final Approval to Manufacture and Market Zolpidem Tablets for Insomnia
Biopharmaceuticals Generics FDA

HSMN NewsFeed - 25 Apr 2007
Ranbaxy Receives Approval to Manufacture and Market Pravastatin Sodium Tablets in U.S.
Biopharmaceuticals Generics FDA

HSMN NewsFeed - 11 Apr 2007
Ranbaxy Receives Approval To Market Cefprozil Tablets and Cefprozil Powder For Oral Suspension in Canada
Biopharmaceuticals Generics Regulatory

HSMN NewsFeed - 8 Feb 2007
Ranbaxy Gains Final Approval for Sertraline Hydrochloride Tablets
Biopharmaceuticals Generics FDA

HSMN NewsFeed - 2 Feb 2007
Valtrex (valacyclovir) - US Patent Litigation Update
Biopharmaceuticals Generics Litigation

HSMN NewsFeed - 1 Feb 2007
Ranbaxy Receives Final FDA Approval to Manufacture and Market Valacyclovir HCl Tablets
Biopharmaceuticals Generics FDA

HSMN NewsFeed - 31 Jan 2007
Ranbaxy Gains FDA Approval to Market Amoxicillin and Clavulanate Potassium for Oral Suspension USP
Biopharmaceuticals Generics FDA

HSMN NewsFeed - 2 Jan 2007
Ranbaxy Granted Final U.S. FDA Approval to Manufacture and Market Atenolol Tablets
Biopharmaceuticals Generics FDA

HSMN NewsFeed - 21 Dec 2006
Ranbaxy Granted Final FDA Approval to Market Simvastatin 5, 10, 20 and 40 mg Tablets
Biopharmaceuticals Generics FDA

HSMN NewsFeed - 14 Dec 2006
Ranbaxy Is Granted Final Approval to Manufacture and Market Cefprozil Anti- Infective Tablets
Biopharmaceuticals Generics FDA

HSMN NewsFeed - 2 Nov 2006
Ranbaxy Receives Tentative Approval to Manufacture and Market Cetirizine Hydrochloride Syrup
Biopharmaceuticals Generics FDA

HSMN NewsFeed - 21 Sep 2006
Ranbaxy Receives Approval to Commercialize Furosemide Tablets in the U.S.
Biopharmaceuticals Generics FDA

HSMN NewsFeed - 30 Jun 2006
Ranbaxy Receives Approval to Market Cefprozil Suspension
Biopharmaceuticals Generics FDA

HSMN NewsFeed - 23 Jun 2006
Ranbaxy Receives FDA Approval to Market Simvastatin 80mg Tablets with 180-Day Exclusivity
Biopharmaceuticals Generics FDA

HSMN NewsFeed - 2 Jun 2006
Ranbaxy Receives Approval To Market Doxycycline Tablets
Biopharmaceuticals Generics FDA

Return to NewsFeed

Additional items found! 83

Members: click here for search results from The HSMN Archive (password required)

Members Archive contains 83 additional stories matching:
Ranbaxy Pharmaceuticals
(Password required)

FindReps - Find Great Medical Independent Sales Reps without recruiter fees.

FindReps - available on the Apple App Store for iPhone and iPad.